CAR-T stands for Chimeric Antigen Receptor T-cell therapy. Doctors harvest the patient’s T cells, the soldiers of the immune ...

Partnership enables ImmunoACT to offer eligible patients a bridge financing plan and value-based offering to access its ...

During a live event, Thomas G. Martin, MD, discussed the importance of controlling disease and avoiding barriers to access so patients with multiple myeloma can receive CAR T-cell therapy.

ImmunoAdoptive Cell Therapy (ImmunoACT), a pioneer in cell and gene therapy, announced a strategic partnership with US firm ...

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...

Researchers at UCLA have created an “off-the-shelf" cell-based immunotherapy that can seek out and destroy pancreatic cancer ...

Don't get me wrong, I love him, will care for him, and protect him. I just don't like having three kids. I never wanted three ...

Major US non-profit Caring Cross announced a collaboration with the Amrita Research Center, based in Delhi, India, to bring ...

Bristol Myers Squibb BMY obtained the European Commission’s (“EC”) approval for a label expansion of Breyanzi (lisocabtagene ...

KOL panel to discuss how vispa-cel, an anti-CD19 allogeneic CAR-T cell therapy, can broaden access for patients with second-line large B cell lymphoma including through use in the community setting ...

Cell therapies, which have made waves in the treatment of blood cancer, are showing potential for solid tumors.

Brilliant Minds Season 2 has been gradually climbing towards the grand finale, and Episode 10 throws a nail-biting, ...